Sugammadex is an agent for reversal of neuromuscular blockade by the agent rocuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA).
It is still in R&D stage.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sugammadex is a <strong>selective relaxant binding agent</strong> used to reverse neuromuscular blockade. It encapsulates rocuronium or vecuronium via cyclodextrin technology. Molecular formula: C<sub>54</sub>H<sub>80</sub>N<sub>12</sub>O<sub>27</sub>; CAS No.: 394674-20-9.</p>
<h3>Application</h3>
<ul>
<li><strong>Anesthesia Management:</strong> Rapid reversal of neuromuscular blockade in surgical procedures.</li>
<li><strong>Emergency Airway:</strong> Immediate management of difficult intubation scenarios requiring quick recovery.</li>
<li><strong>ICU Settings:</strong> Facilitating early extubation and patient mobilization post-surgery.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with severe hypersensitivity to the drug or excipients. Requires strict storage at controlled room temperature (20°C–25°C) to maintain stability. Monitor for bradycardia and anaphylaxis during administration.</p>